Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Inventory: 2023-2024

Historic Inventory for BioLineRx (BLRX) over the last 2 years, with Dec 2024 value amounting to $3.1 million.

  • BioLineRx's Inventory fell 21.57% to $2.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.9 million, marking a year-over-year decrease of 21.57%. This contributed to the annual value of $3.1 million for FY2024, which is 61.03% up from last year.
  • Latest data reveals that BioLineRx reported Inventory of $3.1 million as of FY2024, which was up 61.03% from $2.0 million recorded in FY2023.
  • In the past 5 years, BioLineRx's Inventory registered a high of $3.1 million during FY2024, and its lowest value of $2.0 million during FY2023.
  • For the 2-year period, BioLineRx's Inventory averaged around $2.5 million, with its median value being $2.5 million (2023).
  • Data for BioLineRx's Inventory shows a peak YoY spiked of 61.03% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows BioLineRx's Inventory stood at $2.0 million in 2023, then surged by 61.03% to $3.1 million in 2024.